Maintenance fees coming due
Bayer Pharma Aktiengesellschaft
42 maintenance fees come due in the 12 months from Nov 14, 2026, the next on Nov 19, 2026. Unpaid by May 19, 2027, that one lapses early.
A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5
and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the
six month grace period that follows.
| Patent | Title | Holder | Status | Fee due | Lapses if unpaid | Expires | Confidence |
|---|---|---|---|---|---|---|---|
| US 9,035,023 | Bombesin Analog Peptide Antagonist Conjugates In force Fee due Nov 19, 2026 Lapses if unpaid May 19, 2027 · High confidence | Bayer Pharma Aktiengesellschaft | In force | Nov 19, 2026 | May 19, 2027 | High confidence | |
| US 11,660,301 | Combination of Atr Kinase Inhibitors with Parp Inhibitors In force Fee due Nov 30, 2026 Lapses if unpaid Jun 1, 2027 · High confidence | Bayer Pharma Aktiengesellschaft | In force | Nov 30, 2026 | Jun 1, 2027 | High confidence | |
| US 11,660,351 | Antibody Drug Conjugates (ADCS) Having Enzymatically Cleavable Groups In force Fee due Nov 30, 2026 Lapses if unpaid Jun 1, 2027 · High confidence | Bayer Aktiengesellschaft and Bayer Pharma Aktiengesellschaft | In force | Nov 30, 2026 | Jun 1, 2027 | High confidence | |
| US 10,308,634 | New Substituted Indazoles, Methods for the Production Thereof, Pharmaceutical Preparations That Contain Said New Substituted Indazoles, and Use of Said New Substituted Indazoles to Produce Drugs In force Fee due Dec 4, 2026 Lapses if unpaid Jun 4, 2027 · High confidence | Bayer Pharma Aktiengesellschaft | In force | Dec 4, 2026 | Jun 4, 2027 | High confidence | |
| US 11,667,675 | Masp Inhibitory Compounds and Uses Thereof In force Fee due Dec 6, 2026 Lapses if unpaid Jun 7, 2027 · High confidence | Bayer Aktiengesellschaft | In force | Dec 6, 2026 | Jun 7, 2027 | High confidence | |
| US 9,051,316 | Substituted 4-ARYL-1,4-Dihydro-1,6-Naphthyridine Amides and Their Use In force Fee due Dec 9, 2026 Lapses if unpaid Jun 9, 2027 · High confidence | Bayer Pharma Aktiengesellschaft | In force | Dec 9, 2026 | Jun 9, 2027 | High confidence | |
| US 10,316,001 | Method for Producing (4S)-4-[4-Cyano-2-(METHYLSULFONYL)PHENYL]-3,6-Dimethyl-2-OXO-1-[3-(TRIFLUOROMETHYL)PHENYL]-1,2,3,4-Tetrahydro PYRIMIDINE-5-Carbonitrile In force Fee due Dec 11, 2026 Lapses if unpaid Jun 11, 2027 · High confidence | PH Pharma Co. Ltd. | In force | Dec 11, 2026 | Jun 11, 2027 | High confidence | |
| US 10,323,020 | Substituted Piperidinyl Tetrahydroquinolines In force Fee due Dec 18, 2026 Lapses if unpaid Jun 21, 2027 · Medium confidence | Bayer Pharma Aktiengesellschaft | In force | Dec 18, 2026 | Jun 21, 2027 | Medium confidence | |
| US 11,684,621 | Combination Containing SGC Stimulators and Mineralocorticoid Receptor Antagonists In force Fee due Dec 27, 2026 Lapses if unpaid Jun 28, 2027 · Medium confidence | Bayer Pharma Aktiengesellschaft | In force | Dec 27, 2026 | Jun 28, 2027 | Medium confidence | |
| US 11,684,672 | Combinations of Copanlisib with ANTI-PD-1 Antibody In force Fee due Dec 27, 2026 Lapses if unpaid Jun 28, 2027 · High confidence | Bayer Pharma Aktiengesellschaft | In force | Dec 27, 2026 | Jun 28, 2027 | High confidence | |
| 32 more maintenance fees coming due in the 12 months from Nov 14, 2026 · Pro | |||||||
10 of 42 patents shown. Soonest fee due date first, then patent number.
Pro members see every patent with a maintenance fee coming due: number, title, status, the due date, and the date it lapses if the fee goes unpaid through the grace period.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.